Mette Kristin Lund • 1959 • Greåker • 10 roles • 9 shareholdings

This website uses cookies to enhance the user experience.

Roles

Boards

Name	Role	Total operating income	Total equity	Shares
P PHARMAPAC AS	Board Member	-	29,368	50 % directly
V VITAMAX AS	Board Member	-	2,982,742	50 % indirectly
B BIOPHARMA AS	Board Member	28,277,574	5,851,092	40.31 % indirectly
P PHARMATECH AS	Alternate Member	424,981,522	32,188,248	40.31 % indirectly
B BIOSAN AS	Alternate Member	5,195,708	8,617,973	40.31 % indirectly
G GME LUND HOLDING AS	Chairman	-	15,881,277	40.31 % directly
M MULTILAB ØSTFOLD AS	Alternate Member	5,993,815	1,698,979	40.31 % indirectly
F FARMATEKET AS	Alternate Member	150,213	462,090	40.31 % indirectly
B BIO-SAN ANS	Participant with Joint and Several Liability (Full Responsibility)	-	-	-
L LAVENDULA ANS	Participant with Joint and Several Liability (Full Responsibility)	-	-	-

Last update: Apr 13, 2023

Related industries3

Direct relationships4

Shares owned by Mette Kristin Lund

Name	Share class	Total operating income	Total equity	Share
P PHARMAPAC AS	Ordinære aksjer	0	29,368	50 % directly
V VITAMAX AS		0	2,982,742	50 % indirectly
G GME LUND HOLDING AS	Ordinære aksjer	0	15,881,277	40.31 % directly
B BIOPHARMA AS		28,277,574	5,851,092	40.31 % indirectly
P PHARMATECH AS		424,981,522	32,188,248	40.31 % indirectly
B BIOSAN AS		5,195,708	8,617,973	40.31 % indirectly
M MULTILAB ØSTFOLD AS		5,993,815	1,698,979	40.31 % indirectly
F FARMATEKET AS		150,213	462,090	40.31 % indirectly
L LUND EIENDOM FREDRIKSTAD AS		8,549,760	24,042,431	40.31 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025